QSR:NYSERestaurant Brands International Inc. Analysis
Data as of 2026-06-12 - not real-time
$73.90
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Restaurant Brands International delivered a solid Q1 2026 performance, beating consensus revenue expectations with a 7.3% year‑over‑year increase to $2.26 billion and a non‑GAAP EPS of $0.86 that topped forecasts. The stock is trading just below its 20‑day simple moving average (~$74) while the 20‑day SMA sits under the 50‑day SMA, indicating a modest short‑term bias, and the MACD line has crossed just above the signal line, delivering a bullish histogram signal amid rising volume. Fundamentally, the company maintains healthy operating margins (≈26%) and a strong free‑cash‑flow generation that comfortably covers its 3.5% dividend, though the payout ratio hovers around 80%.
Valuation concerns arise from elevated multiples (P/E ≈24, P/B ≈7) and a DCF‑derived fair value far below the current price, compounded by a very high debt‑to‑equity ratio that amplifies financial risk. The stock’s beta is low, volatility is moderate (~27% 30‑day), and the consumer‑cyclical sector faces typical regulatory and geographic exposures. Overall, the earnings beat and dividend yield support a short‑term buying opportunity, but the overvalued pricing and leverage suggest a more cautious stance for medium‑ to long‑term horizons.
Valuation concerns arise from elevated multiples (P/E ≈24, P/B ≈7) and a DCF‑derived fair value far below the current price, compounded by a very high debt‑to‑equity ratio that amplifies financial risk. The stock’s beta is low, volatility is moderate (~27% 30‑day), and the consumer‑cyclical sector faces typical regulatory and geographic exposures. Overall, the earnings beat and dividend yield support a short‑term buying opportunity, but the overvalued pricing and leverage suggest a more cautious stance for medium‑ to long‑term horizons.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Q1 earnings beat and revenue acceleration
- Bullish MACD crossover with increasing volume
- Attractive dividend yield with sustainable cash flow
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Strong operating margins and cash generation
- High leverage raising financing risk
- Valuation still above fair‑value benchmarks
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Brand portfolio resilience and dividend income
- Persistent overvaluation relative to DCF
- Elevated debt levels limiting upside potential
Key Metrics & Analysis
Financial Health
Revenue Growth7.30%
Profit Margin9.96%
P/E Ratio23.8
ROE28.14%
ROA6.44%
Debt/Equity296.41
P/B Ratio6.9
Op. Cash Flow$1.7B
Free Cash Flow$1.6B
Technical Analysis
TrendNeutral
RSI46.7
Support$70.99
Resistance$77.35
MA 20$74.20
MA 50$76.74
MA 200$70.57
MACDBullish
VolumeIncreasing
Fear & Greed Index87.21
Valuation
Fair Value$32.25
Target Price$85.92
Upside/Downside16.27%
GradeOvervalued
TypeGrowth
Dividend Yield3.52%
Risk Assessment
Beta0.19
Volatility26.94%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.